All In Biotech

Drug Trial Radar · NCT03424018

An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia

Last checked: Nov 19, 2026Latest source record: Mar 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

119

Actual

Start

Dec 12, 2017

Primary completion

Jun 2031

Study completion Jun 2031

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Feb 6, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The intent and design of this Phase 3 study is to assess BMN 111 as a therapeutic option for the treatment of children with Achondroplasia

Conditions

  • Achondroplasia

Interventions

  • BMN 111Drug

    Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baselines in mean annualized growth velocityTime frame: Through study completion, an average of 1 year

Locations

24 sites in 7 countries. Site status is shown where the registry gives one.

  • Children's Hospital & Research Center Oakland

    Oakland, California

  • Harbor - UCLA Medical Center

    Torrance, California

  • Alfred I. duPont Hospital for Children

    Wilmington, Delaware

  • Emory University

    Atlanta, Georgia

  • Ann and Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Johns Hopkins University

    Baltimore, Maryland

  • University of Missouri

    Columbia, Missouri

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Baylor College of Medicine

    Houston, Texas

  • Seattle Children's Hospital

    Seattle, Washington

  • Medical College of Wisconsin, Children's Hospital

    Milwaukee, Wisconsin

  • The Children's Hospital at Westmead

    Westmead, New South Wales, Australia

  • Murdoch Children's Research Institute

    Parkville, Victoria, Australia

  • Otto-von-Gericke Universitaet, Universitaetskinderklinik

    Magdeburg, Germany

  • Universitätsklinikum Münster

    Münster, Germany

  • Osaka University Hospital

    Osaka, Japan

  • Saitama Children's Medical Center

    Saitama, Japan

  • Tokushima University Hospital

    Tokushima, Japan

  • Institut Catala de Traumatologica I Medicina de l'Esport

    Barcelona, Spain

  • Hospital Sant Joan de Deu

    Barcelona, Spain

  • Hospital Universitario Virgen de la Victoria

    Málaga, Spain

  • Acibadem University School of Medicine

    Istanbul, Turkey (Türkiye)

  • Guy's and St. Thomas NHS Foundation Trust Evelina Children's Hospital

    London, United Kingdom

  • Sheffield Children's NHS Foundation Trust

    Sheffield, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.